Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Author:
Affiliation:
1. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York
2. Weill Cornell Medical College; New York New York
3. Internal Medicine/Hematology and Oncology; American University of Beirut; Beirut Lebanon
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29769/fullpdf
Reference121 articles.
1. Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma;Postow;Cancer J,2012
2. Treating advanced hepatocellular carcinoma: how to get out of first gear;Harding;Cancer,2014
3. Immune surveillance by the liver;Jenne;Nat Immunol,2013
4. Antigen-presenting cell function in the tolerogenic liver environment;Thomson;Nat Rev Immunol,2010
5. Efficient presentation of exogenous antigen by liver endothelial cells to CD8 + T cells results in antigen-specific T-cell tolerance;Limmer;Nat Med,2000
Cited by 107 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights;Frontiers in Immunology;2024-07-16
2. N6-methyladenosine (m6A) modification in hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-04
3. Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma;World Journal of Clinical Cases;2024-01-16
4. Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma;Frontiers in Genetics;2023-08-21
5. Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy;Pathology - Research and Practice;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3